Patents by Inventor Kristi M. Moore

Kristi M. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified DNA molecule, recombinant containing the same, and uses thereof
    Patent number: 6936707
    Abstract: There is provided a DNA molecule derived from a prokaryotic cell in which at least one of the DNA regions encoding NXB (N is asparagine, X is any amino acid other than proline, and B is serine or threonine) has been modified so that no N-glycosylation occurs during the expression in a eukaryotic cell, and since the DNA molecule has been modified at the N-glycosylation site, it produces a non-N-glycosylated protein, which thereby exhibits a high immunogenicity when, for example, it is allowed to produce, in a eukaryotic cell, an antigen protein derived from a prokaryotic cell.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: August 30, 2005
    Assignee: Zeon Corporation
    Inventors: Takashi Okuda, Shuji Saito, Kristi M. Moore, Yoshinari Tsuzaki
  • Avian herpesvirus-based recombinant infectious bursal disease vaccine
    Patent number: 6764684
    Abstract: The present invention provides an avian recombinant herpesvirus modified by the presence of the cDNA encoding the VP2 of the Delaware Variant E strain of IBDV, a subtype of IBDV serotype 1 strains. The present invention further provides an avian recombinant herpesvirus comprised of the VP2 gene, of which the backbone virus is a Marek's disease vaccine strain, such as herpesvirus of turkeys. A poultry vaccine including the avian herpes recombinant virus described in the present invention can induce in chickens protective immunity against a variety of different subtypes of IBDV.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: July 20, 2004
    Assignee: Zeon Corporation
    Inventors: Shuji Saitoh, Takashi Okuda, Mayumi Kubomura, Kristi M. Moore
  • Modified DNA molecule, recombinant containing the same, and uses thereof
    Publication number: 20030165534
    Abstract: There is provided a DNA molecule derived from a prokaryotic cell in which at least one of the DNA regions encoding NXB (N is asparagine, X is any amino acid other than proline, and B is serine or threonine) has been modified so that no N-glycosylation occurs during the expression in a eukaryotic cell, and since the DNA molecule has been modified at the N-glycosylation site, it produces a non-N-glycosylated protein, which thereby exhibits a high immunogenicity when, for example, it is allowed to produce, in a eukaryotic cell, an antigen protein derived from a prokaryotic cell.
    Type: Application
    Filed: July 11, 2001
    Publication date: September 4, 2003
    Inventors: Takashi Okuda, Shuji Saito, Kristi M. Moore, Yoshinari Tsuzaki
  • Avian herpesvirus-based recombinant infectious bursal disease vaccine
    Publication number: 20030099667
    Abstract: The present invention provides an avian recombinant herpesvirus modified by the presence of the cDNA encoding the VP2 of the Delaware Variant E strain of IBDV, a subtype of IBDV serotype I strains. The present invention further provides an avian recombinant herpesvirus comprised of the VP2 gene, of which the backbone virus is a Marek's disease vaccine strain, such as herpesvirus of turkeys. A poultry vaccine including the avian herpes recombinant virus described in the present invention can induce in chickens protective immunity against a variety of different subtypes of IBDV.
    Type: Application
    Filed: September 28, 2001
    Publication date: May 29, 2003
    Inventors: Shuji Saitoh, Takashi Okuda, Mayumi Kubomura, Kristi M. Moore